Carcinoma, Non-Small-Cell LungPhase 3NCT06875310
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
A Phase 3 study testing Adagrasib, Pembrolizumab and Carboplatin in people with Carcinoma, Non-Small-Cell Lung, run by Mirati Therapeutics Inc. at 317 sites in 35 countries.
Trial summary
This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet chemotherapy versus placebo plus pembrolizumab plus platinum-doublet chemotherapy in participants with previously untreated, locally advanced or metastatic NSCLC with KRAS G12C mutation Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Carcinoma, Non-Small-Cell Lung
- What is being tested?
- Adagrasib, Pembrolizumab and Carboplatin
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 630 participants
- Where
- 317 sitesin 35 countries
- Study dates
- 24 Apr 2025to 30 Apr 2032
- Phase
- Phase 3
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Histologically or cytologically confirmed diagnosis of non-squamous NSCLC with evidence of KRAS G12C mutation via tumor sample and/or circulating tumor deoxyribonucleic acid (ctDNA).
- Locally advanced or metastatic disease.
- Measurable disease via computed tomography (CT) or magnetic resonance imaging (MRI) per RECIST v1.1 criteria of at least 1 lesion.
- No prior systemic anti-cancer therapy given for advanced or metastatic disease.
- Not a candidate for definitive therapy (eg, chemoradiation or complete surgical resection).
- Participants with brain metastases are eligible for enrollment, including those with untreated brain metastases. Brain metastases must be asymptomatic and not in need of immediate local therapy. Any untreated brain metastases must be ≤ 20 mm in diameter.
- Any PD-L1 expression (0 to 100%) as determined by VENTANA PD-L1 (SP263) assay, Agilent PD-L1 IHC 22C3 pharmDx, or Agilent PD-L1 IHC 28-8 pharmDx.
Who cannot join
- Participants with an active autoimmune or inflammatory disease requiring systemic treatment within 2 years.
- Uncontrolled or significant cardiovascular conditions within 6 months prior to enrollment that are ongoing or with risk of recurrence.
- Inadequate bone marrow or liver function or electrocardiogram (ECG) abnormalities.
- Ongoing treatment with concomitant medication known to cause prolonged QTc interval and that cannot be switched to alternative treatment prior to study entry.
- Treatment targeting KRAS G12C mutation (eg, sotorasib, adagrasib) in any setting.
- Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or study drug administration.
- Other protocol-defined Inclusion/Exclusion criteria apply.
Trial locations and contacts
317 sites in 35 countries. Contact the study team or a site near you to ask about taking part.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com contact
First line of the email MUST contain NCT # and Site #. contact
317 sites in 35 countries
United States46 sites, 46 recruiting
- Recruiting
Velocity Clinical Research, Annapolis
Annapolis, Maryland, 21401
Fayez Estephan, Site 0702
- Recruiting
Illinois Cancer Specialists
Arlington Heights, Illinois, 60005
David Hakimian, Site 0665, 847-827-9060
- Recruiting
University of Alabama at Birmingham
Birmingham, Alabama, 35294
Maya Khalil, Site 0347, 205-975-2833
- Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215
Pasi Janne, Site 0019, 617-632-6036
- Recruiting
Mercy Medical Center
Cedar Rapids, Iowa, 52403
Ann Stroh, Site 0691
- Recruiting
University of Illinois at Chicago
Chicago, Illinois, 60612
Frank Weinberg, Site 0676
- Recruiting
Morton Plant Hospital - BayCare Health System
Clearwater, Florida, 33756
Vijayakrishna Gadiyaram, Site 0694, 727-462-3692
- Recruiting
Maryland Oncology Hematology - Columbia
Columbia, Maryland, 21044
Mohit Narang, Site 0385, 817-837-8660
- Not yet recruiting
Local Institution - 0678
Cooperstown, New York, 13326
Site 0678
- Recruiting
Texas Oncology Sammons Cancer Center
Dallas, Texas, 75246
Kartik Konduri, Site 0034, 214-370-1000
- Recruiting
National Jewish Health Medical Center
Denver, Colorado, 80206
Laurie Carr, Site 0442, 303-388-4461
- Recruiting
Karmanos Cancer Institute
Detroit, Michigan, 48201
Hirva Mamdani, Site 0293, 909-525-0093
- Recruiting
Northwest Cancer Centers, P.C.
Dyer, Indiana, 46311
Shruti Singh, Site 0454, 219-924-8178
- Recruiting
Saint Elizabeth Medical Center Edgewood
Edgewood, Kentucky, 41017
Colleen Darnell, Site 0366, 859-301-4000
- Recruiting
SSM Health Cancer Care - Fenton
Fenton, Missouri, 63026
Mudresh Mehta, Site 0685
- Recruiting
Parkview Research Center at Parkview Regional Medical Center
Fort Wayne, Indiana, 46845
patricia Rich, Site 0684, 260-266-7100
- Recruiting
Providence Medical Foundation
Fullerton, California, 92835
David Park, Site 0581, 714-446-5900
- Recruiting
University Of Texas Medical Branch At Galveston
Galveston, Texas, 77555
Maurice Willis, Site 0692, 409-772-1164
- Recruiting
St Francis Cancer Center
Greenville, South Carolina, 29607
Stephen Dyar, Site 0658, 864-603-6327
- Recruiting
Cancer Specialists of North Florida
Jacksonville, Florida, 32256
Laura Lourdes, Site 0052, 904-538-4488
- Recruiting
Oncology & Hematology of South Texas
Laredo, Texas, 78041
Eduardo Miranda, Site 0652, 956-724-8543
- Not yet recruiting
Local Institution - 0682
Loma Linda, California, 92354
Site 0682
- Recruiting
Helios Clinical Research
Long Beach, California, 90805
Omkar Marathe, Site 0202, 562-693-4477
- Recruiting
The University of Louisville, James Graham Brown Cancer Center
Louisville, Kentucky, 40202
Phuong Ngo, Site 0566, 502-562-4358
- Recruiting
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital
Marietta, Georgia, 30060
Walid Shaib, Site 0031, 770-281-5124
- Not yet recruiting
Local Institution - 0696
Miami, Florida, 33176
Site 0696
- Recruiting
SCRI Oncology Partners
Nashville, Tennessee, 37203
David Spigel, Site 0020, 615-320-5090
- Not yet recruiting
Local Institution - 0697
Nashville, Tennessee, 37212
Site 0697
- Recruiting
Medical Oncology Hematology Consultants, PA
Newark, Delaware, 19713
Jamal Misleh, Site 0701, 302-366-1200
- Recruiting
Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala
Ocala, Florida, 34474
Ketan Doshi, Site 0680, 352-732-4938
- Recruiting
Mid Florida Hematology and Oncology Center
Orange City, Florida, 32763
Santosh Nair, Site 0679, 407-353-1915
- Recruiting
Owensboro Medical Health System
Owensboro, Kentucky, 42303
Jewraj Maheshwari, Site 0693
- Recruiting
Mercy Health-Paducah Medical Oncology and Hematology
Paducah, Kentucky, 42003
Wederson Claudino, Site 0698, 000-000-0000
- Recruiting
Cancer Care Centers of Brevard, Inc.
Palm Bay, Florida, 32901
Venkat Pavan Kancharla, Site 0621, 111-111-1111
- Recruiting
Florida Clinical Trials Group.
Plantation, Florida, 33322
Harshad Amin, Site 0365, 561-447-0614
- Recruiting
Texas Oncology - San Antonio
San Antonio, Texas, 78217
Krishna Alluri, Site 0622, 210-656-7177
- Recruiting
Ellis Hospital
Schenectady, New York, 12308
Tallat Mahmood, Site 0634, 517-331-4405
- Recruiting
Louisiana State University Health Sciences Shreveport
Shreveport, Louisiana, 71103
Kavitha Beedupalli, Site 0644, 318-813-3061
- Recruiting
Highlands Oncology Group - Springdale
Springdale, Arkansas, 72762
Eric Schaefer, Site 0686, 479-872-8130
- Recruiting
Springfield Clinic Main Campus
Springfield, Illinois, 62703
Preet Singh, Site 0683, 205-919-3812
- Recruiting
St. Anthony's Hospital
St. Petersburg, Florida, 33705
Ahmad Shaker, Site 0695
- Recruiting
Florida Clinical Trials Group.
Tamarac, Florida, 33321
Chintan Gandhi, Site 0377, 561-447-0614
- Recruiting
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, 33612
Andreas Saltos, Site 0699, 813-745-6895
- Recruiting
Texas Oncology - Northeast Texas
Tyler, Texas, 75702
Shail Dalal, Site 0700, 903-727-2200
- Recruiting
White Plains Hospital
White Plains, New York, 10601
Daniel Sammartino, Site 0618, 914-849-7600
- Recruiting
WellSpan Oncology Research
York, Pennsylvania, 17403
Ikechukwu Akunyili, Site 0657, 717-339-2560
China40 sites, 40 recruiting
- Recruiting
Beijing Cancer hospital
Beijing, Beijing Municipality, 100142
Jian Fang, Site 0355, 861088196479
- Recruiting
Beijing Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730
mengzhao wang, Site 0491, 13911235467
- Recruiting
Beijing Chest Hospital,Capital Medical University
Beijing, Beijing Municipality, 101149
Zhe Liu, Site 0397, 010-8909303
- Recruiting
The First Afflilated Hospital of Bengbu Medical College
Bengbu, Anhui, 233017
Chengling Zhao, Site 0482, +8618105527755
- Recruiting
The First Hospital of Jilin University
Changchun, Jilin, 130021
Kewei Ma, Site 0483, 8613756060506
- Recruiting
Hunan Cancer Hospital
Changsha, Hunan, 410013
Lin Wu, Site 0398, 8613170419973
- Recruiting
Sichuan Cancer hospital
Chengdu, Sichuan, 610041
Wenxiu Yao, Site 0667, 18908178836
- Recruiting
West China Hospital, Sichuan University
Chengdu, Sichuan, 610041
Yongsheng Wang, Site 0384, 8618980602258
- Recruiting
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, 400030
Dan Yang, Site 0490, +8613983895620
- Recruiting
Fujian Medical University Union Hospital
Fuzhou Fujian, Fujian, 350001
Xiaoyan Lin, Site 0362, 8613950482366
- Recruiting
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 0
Kejing Tang, Site 0469, 8613802946566
- Recruiting
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510140
Chengzhi Zhou, Site 0625, 13560351176
- Recruiting
The first Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310003
Yihong Shen, Site 0462, 13958106605
- Recruiting
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310016
Yong Fang, Site 0492, 8613588491264
- Recruiting
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310022
Yun Fan, Site 0463, 8657188122188
- Recruiting
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, 150081
Yan Yu, Site 0465, 13904505825
- Recruiting
Anhui Provincial Hospital
Hefei, Anhui, 230001
Junqiang Zhang, Site 0475, 8618955142161
- Recruiting
Shandong Cancer Hospital
Jinan, Shandong, 250117
Haiyong Wang, Site 0474, 15665878316
- Recruiting
LinYi Cancer Hospital
Linyi, Shandong, 276001
Jianhua Shi, Site 0359, +8615963998868
- Recruiting
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330006
Anwen Liu, Site 0467, 8613767120022
- Recruiting
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, 210000
Lifeng Wang, Site 0371, 13951699955
- Recruiting
Guangxi Medical University Affiliated Tumor Hospital
Nanning, Guangxi, 530021
Aiping Zeng, Site 0464, 13367816089
- Recruiting
Nanyang City Center Hospital
Nanyang, Henan, 473009
Lixin Wan, Site 0626, +8613838708656
- Recruiting
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, 200030
Hua Zhong, Site 0470, 13818200560
- Recruiting
Shanghai East Hospital
Shanghai, Shanghai Municipality, 200120
Caicun Zhou, Site 0354, 8613301825532
- Recruiting
Cancer Hospital of Shantou University Medical College
Shantou, Guangdong, 515041
Wen Lin, Site 0356, 13612388011
- Recruiting
The First Hospital of China Medical University
Shenyang, Liaoning, 110001
Bo Jin, Site 0473, 13604923020
- Recruiting
Shengjing Hospital of China Medical University
Shenyang, Liaoning, 110004
Xiaoye Zhang, Site 0479, 18940259600
- Recruiting
Liaoning Cancer Hospital
Shenyang, Liaoning, 110042
Rui Ma, Site 0493, 13304006343
- Recruiting
Cancer Hospital Chinese Academy of Medical Sciences. Shenzhen Center
Shenzhen, Guangdong, 0
Jianhua Chang, Site 0461, 8618017312689
- Recruiting
ShenZhen People's Hospital
Shenzhen, Guangdong, 518020
Di Wu, Site 0352, 8613662589160
- Recruiting
Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050035
Ping Wang, Site 0472, 13931130696
- Recruiting
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215006
Chuanyong Mu, Site 0382, 18912615299
- Recruiting
Shanxi Cancer Hospital
Taiyuan, Shanxi, 030000
Jianchun Duan, Site 0353, 86+13811259820
- Recruiting
Taizhou Hospital of Zhejiang Province
Taizhou, Zhejiang, 317000
Dongqing LV, Site 0374, 13867622009
- Recruiting
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, 300052
Diansheng Zhong, Site 0460, 13821377353
- Recruiting
Tongji Hospital Tongji Medical,Science & Technology
Wuhan, Hubei, 430030
Qian Chu, Site 0373, 8613212760751
- Recruiting
The First Affiliated hospital of Xiamen University
Xiamen, Fujian, 361003
Feng Ye, Site 0383, 8613860458889
- Recruiting
The First Affiliated Hospital of Henan Medical University
Xinxiang, Henan, 453100
Yinghua Ji, Site 0494, 8613663030446
- Recruiting
Northern Jiangsu People's Hospital
Yangzhou, Jiangsu, 225001
Buhai Wang, Site 0378, 8613813194298
Germany18 sites, 18 recruiting
- Recruiting
Vivantes Klinikum Neukölln
Berlin, 12351
Maike De Wit, Site 0526, 0000000000
- Recruiting
Evangelische Lungenklinik Berlin
Berlin, 13125
Christian Grohe, Site 0537, +493094802112
- Recruiting
Klinikum Köln-Merheim
Cologne, North Rhine-Westphalia, 51109
Carolin Groß-Ophoff-Müller, Site 0523, +49 221 8907-13962
- Recruiting
Klinikum Esslingen
Esslingen am Neckar, Baden-Wurttemberg, 73730
Martin Faehling, Site 0534, +4971131032402
- Recruiting
Malteser Krankenhaus St. Franziskus-Hospital
Flensburg, Schleswig-Holstein, 24939
Nicolai Faber, Site 0521, 04618162782
- Recruiting
Centrum für Hämatologie und Onkologie Bethanien
Frankfurt am Main, Hesse, 60389
Oliver Waidmann, Site 0518, 06956005626
- Recruiting
SRH Wald-Klinikum Gera GmbH
Gera, Thuringia, 07548
Dagmar Täuscher, Site 0524, 493658287758
- Recruiting
UKGM Gießen/Marburg
Giessen, Hesse, 35392
Thomas Wehler, Site 0535, 0049064198558544
- Recruiting
Universitätsklinikum Halle
Halle, Saxony-Anhalt, 06120
Stephan Eisenmann, Site 0522, +4903455591429
- Recruiting
Praxis Onkologie am Raschplatz
Hanover, Lower Saxony, 30161
Eyck von der Heyde, Site 0520, 0177-6506614
- Recruiting
Lungenklinik Hemer
Hemer, 58675
Karsten Schulmann, Site 0528, 02372-9082560
- Recruiting
Evangelisches Krankenhaus Herne - Eickel
Herne, North Rhine-Westphalia, 44651
Daniel Christoph, Site 0603, +49232349892793
- Recruiting
Universitätsklinikum Jena
Jena, Thuringia, 07747
Jakob Hammersen, Site 0551, 4936419396622
- Recruiting
Klinikum der Ludwig-Maximilians-Universitaet Muenchen
München, Bavaria, 81377
Amanda Tufman, Site 0557, 4989440057545
- Recruiting
Pius Hospital Oldenburg
Oldenburg, Lower Saxony, 26121
Frank Griesinger, Site 0527, 494412291611
- Recruiting
Klinikum Stuttgart - Katharinenhospital
Stuttgart, 70174
Cornelia Kropf-Sanchen, Site 0517, +4973150045230
- Recruiting
Bundeswehrkrankenhaus Ulm
Ulm, Baden-Wurttemberg, 89081
Matthias Mueller, Site 0670, +490731171031253
- Recruiting
Universitaetsklinikum Wuerzburg
Würzburg, 97080
Horst Dieter Hummel, Site 0525, + 49 931 201-40916
France16 sites, 16 recruiting
- Recruiting
CHU d'Amiens-Picardie - Hôpital Sud
Amiens, Somme, 80054
Claire Poulet, Site 0552, 0322087990
- Recruiting
Centre Hospitalier Universitaire d'Angers
Angers, Maine-et-Loire, 49933
Youssef Oulkhouir, Site 0560, 33231064676
- Recruiting
Hôpital Ambroise Paré
Boulogne-Billancourt, 92100
Etienne Giroux-Leprieur, Site 0513
- Recruiting
CHRU de Brest
Brest, Finistère, 29200
Jessica NGUYEN, Site 0512, 0230338534
- Recruiting
Centre François Baclesse
Caen, Calvados, 14076
Hubert CURCIO, Site 0296, 0231455050
- Recruiting
Chu Gabriel Montpied
Clermont-Ferrand, 63000
Patrick MERLE, Site 0134, 0473751649
- Recruiting
Centre Georges François Leclerc
Dijon, Côte-d'Or, 21079
Coureche Kaderbhai, Site 0605, 33380737504
- Recruiting
Chu Grenoble Alpes
La Tronche, Isère, 38700
Denis Moro-Sibilot, Site 0220, 33476765467
- Recruiting
Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren
Limoges, 87042
Thomas Egenod, Site 0604, 33555056892
- Recruiting
Institut Paoli-Calmettes
Marseille, Provence-Alpes-Côte d'Azur Region, 13273
Anne Madroszyk, Site 0636, 33491223789
- Recruiting
Assistance Publique Hôpitaux de Marseille - Hôpital Nord
Marseille, 13915
Laurent Greillier, Site 0164, 33491324400
- Recruiting
Institut Régional du Cancer Montpellier
Montpellier, Hérault, 34298
Xavier Quantin, Site 0558, 33467614533
- Recruiting
Hopitaux Universitaires Paris Centre-Hopital Cochin
Paris, 75679
Marie Wislez, Site 0158, 33158413091
- Recruiting
Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes
Saint-Herblain, 44800
Elvire Pons-Tostivint, Site 0139, +33676133810
- Recruiting
Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois
Vandœuvre-lès-Nancy, Meurthe-et-Moselle, 54511
Bertrand Mennecier, Site 0589, 33383154653
- Recruiting
Gustave Roussy
Villejuif, Val-de-Marne, 94800
Fabrice Barlesi, Site 0213, 33142114211
Brazil15 sites, 15 recruiting
- Recruiting
Fundação Pio XII - Hospital de Câncer de Barretos
Barretos, São Paulo, 14784400
Gustavo Dix Junqueira Pinto, Site 0240, 551733216637
- Recruiting
Cetus Oncologia - Unidade Belo Horizonte
Belo Horizonte, Minas Gerais, 30110-022
Elisa Ramos, Site 0244, 5531998619660
- Recruiting
Clínica de Oncologia Reichow
Blumenau, Santa Catarina, 89010-340
Sandro Reichow, Site 0237, 554733805890
- Recruiting
ONCOSITE - Centro de Pesquisa Clinica em Oncologia
Ijuí, Rio Grande do Sul, 98700-000
Fabio Franke, Site 0235, +5555991592101
- Recruiting
Clínica de Neoplasias Litoral
Itajaí, Santa Catarina, 88301-220
Giuliano Borges, Site 0245, 5547984046243
- Recruiting
Hospital São Lucas da PUCRS
Porto Alegre, Rio Grande do Sul, 90610-000
Ana Caroline Gelatti, Site 0233, (51)3320-3039
- Recruiting
Hospital de Amor Amazônia
Porto Velho, Rondônia, 76834-899
Jéssica Câmara, Site 0243, 38999986193
- Recruiting
Instituto Nacional de Câncer - INCA
Rio de Janeiro, 20230-130
Luiz Henrique Araujo, Site 0236, 552132076585
- Recruiting
Nucleo de Oncologia da Bahia
Salvador, Estado de Bahia, 40170-110
Filipe Visani, Site 0257, +5571983140522
- Recruiting
Instituto de Oncologia Saint Gallen
Santa Cruz do Sul, Rio Grande do Sul, 96830-180
Bianca Correa Tabajara Weiss, Site 0238, 5551991898942
- Recruiting
Advanze Pesquisa
São Carlos, São Paulo, 13561-130
Luiz Agenor Gazzi, Site 0241, 551633711320
- Recruiting
Fundação Faculdade Regional de Medicina de São José do Rio Preto
São José do Rio Preto, São Paulo, 15090-000
JOÃO SOLER, Site 0239, 551732015054
- Recruiting
A. C. Camargo Cancer Center
São Paulo, São Paulo, 01509-010
Vladmir Cordeiro de Lima, Site 0254, +5511976470332
- Recruiting
Icesp - Instituto Do Câncer Do Estado de São Paulo
São Paulo, 01246-000
Milena Perez Mak, Site 0258, 551138932632
- Recruiting
CEDOES
Vitória, Espírito Santo, 29055450
Mauricio Pereira, Site 0242, +5521998795727
India15 sites, 15 recruiting
- Recruiting
Hemato Oncology Clinic
Ahmedabad, Gujarat, 380054
Chirag Desai, Site 0136, 919824047561
- Recruiting
Marengo CIMS Hospital
Ahmedabad, Gujarat, 380060
Bhavesh Parekh, Site 0230, 9825034353
- Recruiting
Institute of Medical Sciences and Sum Hospital
Bhubaneswar, Odisha, 751003
Lalatendu Moharana, Site 0226, 9538752579
- Recruiting
Narayana Superspecialty Hospital
Howrah, West Bengal, 711103
Chandrakanth MV, Site 0161, 7738519198
- Recruiting
Yashoda Hospitals - Hitech City
Hyderabad, Telangana, 500084
Naidu Norman Bethune, Site 0663, 9989489877
- Recruiting
Basavatarakam Indo American Cancer Hospital & Research Institute
Hyderabad, 500034
Senthil Rajappa, Site 0661, 9849213102
- Recruiting
Netaji Subhas Chandra Bose Cancer Hospital
Kolkata, West Bengal, 700094
Poulami Basu, Site 0221, 6290073778
- Recruiting
Meenakshi Mission Hospital and Research Centre
Madurai, Tamil Nadu, 625107
Saju SV, Site 0224, 8891810070
- Not yet recruiting
Local Institution - 0154
Mumbai, Maharashtra, 400012
Site 0154
- Recruiting
All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, 110029
SACHIN KHURANA, Site 0312, 9769030180
- Recruiting
Vardhman Mahavir Medical College and Safdarjung Hospital
New Delhi, National Capital Territory of Delhi, 110029
Kaushal Kalra, Site 0511, 9968663394
- Recruiting
Rajiv Gandhi Cancer Institute And Research Centre
New Delhi, National Capital Territory of Delhi, 110085
Ullas Batra, Site 0135, 919711080001
- Not yet recruiting
Local Institution - 0155
Thiruvananthapuram, Kerala, 695011
Site 0155
- Recruiting
Mahamana Pandit Madan Mohan Malviya Cancer Centre
Varanasi, Uttar Pradesh, 221005
Akhil Kapoor, Site 0153, +915422517699
- Recruiting
Apollo Hospitals - Visakhapatnam - Health City
Visakhapatnam, Andhra Pradesh, 530040
Rakesh Reddy Boya, Site 0222, 555-555-55
Japan15 sites, 15 recruiting
- Recruiting
Aomori Prefectural Central Hospital
Aomori, 030-8553
Takeshi Morimoto, Site 0346, 017-726-8111
- Recruiting
Tokyo Metropolitan Komagome Hospital
Bunkyo Ku, Tokyo, 113-8677
Yukio Hosomi, Site 0674, 81338232101
- Recruiting
Kyushu University Hospital
Fukuoka, 812-8582
Isamu Okamoto, Site 0310, +81926425378
- Recruiting
Hamamatsu University Hospital
Hamamatsu, Shizuoka, 431-3192
Naoki Inui, Site 0606, 81534352356
- Recruiting
Saitama Medical University International Medical Center
Hidaka, Saitama, 350-1298
Hiroshi Kagamu, Site 0303, 819014217189
- Recruiting
Kansai Medical University Hospital
Hirakata, Osaka, 573-1191
Takayasu Kurata, Site 0642, 81728042503
- Recruiting
Nagasaki University Hospital
Nagasaki, 852-8501
Takemoto Shinnosuke, Site 0687, 8195-819-7273
- Recruiting
Local Institution - 0607
Nagoya, Aichi-ken, 457-8510
Site 0607
- Recruiting
National Hospital Organization Nagoya Medical Center
Nagoya, Aichi-ken, 460-0001
Masahide Oki, Site 0305, 81529511111
- Recruiting
Osaka City General Hospital
Osaka, 534-0021
Yuki Nakatani, Site 0297, +81-6-6929-1221
- Recruiting
Osaka International Cancer Institute
Osaka, 541-8567
Motohiro Tamiya, Site 0309, +81-6-6945-1181
- Recruiting
Kitasato University Hospital
Sagamihara, Kanagawa, 252-0375
Katsuhiko Naoki, Site 0302, +81-80-5057-3533
- Recruiting
Hokkaido University Hospital
Sapporo, Hokkaido, 0608648
Jun Sakakibara, Site 0298, +81-11-716-1161
- Recruiting
Sendai Kousei Hospital
Sendai, Miyagi, 9810914
Shunichi Sugawara, Site 0301, 81227288000
- Recruiting
Toyama University Hospital
Toyoma, Toyama, 930-0194
Ryuji Hayashi, Site 0343, +81763437808
Romania13 sites, 10 recruiting
- Recruiting
SC Memorial Healthcare International SRL
Bucharest, Bucharest, 013812
Ingrid Iordan, Site 0272, 40721298677
- Recruiting
Institutul Oncologic Bucuresti "Prof. Dr. Alexandru Trestioreanu"
Bucharest, Bucharest, 022338
Aurelia Alexandru, Site 0261, 40723289606
- Completed
Local Institution - 0276
Cluj-Napoca, Cluj, 400015
- Recruiting
Institutul Oncologic Cluj
Cluj-Napoca, 400015
Tudor Ciuleanu, Site 0273, 40745646368
- Recruiting
Institutul Oncologic Cluj
Cluj-Napoca, 400015
Cristina Cebotaru, Site 0270, 40745976913
- Completed
Local Institution - 0590
Constanța, 900591
- Recruiting
Centrul de Oncologie "Sfântul Nectarie"
Craiova, Dolj, 200542
Michael Schenker, Site 0271, 40727774974
- Recruiting
SC Radiotherapy Center Cluj SRL
Florești, Cluj, 407280
Andrei Ungureanu, Site 0268, 40742206212
- Recruiting
S.C. Centrul de Oncologie Euroclinic S.R.L.
Iași, 700106
Constantin Volovat, Site 0266, 40746110096
- Recruiting
Institutul Regional de Oncologie
Iași, 700483
Dana Clement, Site 0260, 40744692062
- Completed
Local Institution - 0275
Ovidiu, Constanța County, 905900
- Recruiting
Spitalul Municipal Schuller Ploiești
Ploieşti, 100337
Nita Amedeia, Site 0269, +40728121201
- Recruiting
Oncohelp Medical Center
Timișoara, Timiș County, 300239
Daniela Sirbu, Site 0592, 40744571617
Spain13 sites, 13 recruiting
- Recruiting
CHUAC-Hospital Teresa Herrera
A Coruña, A Coruña [La Coruña], 15006
Maria Garcia Campelo, Site 0499, 34981178353
- Recruiting
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona [Barcelona], 08035
Enriqueta Felip Font, Site 0501, 34932746077
- Recruiting
Hospital General Universitario Gregorio Marañon
Madrid, Madrid, Comunidad de, 28009
Antonio Calles Blanco, Site 0500, +34915868115
- Recruiting
Hospital Universitario Ramón y Cajal
Madrid, Madrid, Comunidad de, 28034
Maria Eugenia Olmedo Garcia, Site 0503, 34913368263
- Recruiting
Hospital Universitario 12 de Octubre
Madrid, Madrid, Comunidad de, 28041
Luis Paz-Ares Rodriguez, Site 0496, 0034913908922
- Recruiting
Hospital Clinico San Carlos
Madrid, 28040
Carlos Aguado de la Rosa, Site 0504, +34913307552
- Recruiting
Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, Madrid, Comunidad de, 28222
Mariano Provencio Pulla, Site 0498, 34911917759
- Recruiting
H.R.U Málaga - Hospital General
Málaga, 29011
Manuel Cobo-Dols, Site 0502, 00349422033350000
- Recruiting
Hospital Son Llàtzer
Palma, Illes Balears [Islas Baleares], 07198
Juan Coves Sarto, Site 0508, 348712020001629
- Recruiting
CHUVI- Hospital Alvaro Cunqueiro
Pontevedra, Pontevedra [Pontevedra], 36312
Martin Lazaro Quintela, Site 0669, 34986825801
- Recruiting
CHUS - Hospital Clinico Universitario
Santiago de Compostela, A Coruña [La Coruña], 15706
Jorge Garcia Gonzalez, Site 0506, 34981950511
- Recruiting
Hospital Universitario Virgen Del Rocio
Seville, 41013
Miriam Alonso Garcia, Site 0507, 34955013068
- Recruiting
Hospital Arnau de Vilanova
Valencia, València, 46015
Jose Garcia Sanchez, Site 0640, +34963987700
Italy11 sites, 10 recruiting
- Recruiting
Instituto Tumori Giovanni Paolo II
Bari, Apulia, 70124
Domenico Galetta, Site 0071, 390805555442
- Recruiting
Azienda Ospedaliera Universitaria Careggi
Florence, Tuscany, 50134
Lorenzo Antonuzzo, Site 0069, 00390557947298
- Recruiting
IRCCS AOM Azienda Ospedaliera Metropolitana
Genova, 16132
Carlo Genova, Site 0588, 393397231066
- Recruiting
IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"
Meldola, Emilia-Romagna, 47014
Angelo Delmonte, Site 0067, +393487469100
- Active, not recruiting
Local Institution - 0066
Naples, Napoli, 80131
- Recruiting
Azienda Ospedaliero-Universitaria San Luigi Gonzaga
Orbassano, Piedmont, 10043
Silvia Novello, Site 0070, 390119026322
- Recruiting
Istituto Oncologico Veneto IRCCS
Padova, 35128
Valentina Guarneri, Site 0073, 00390498215931
- Recruiting
Azienda Ospedaliero Universitaria di Parma
Parma, 43126
Marcello Tiseo, Site 0156, 390521702682
- Recruiting
Fondazione IRCCS Policlinico San Matteo
Pavia, 27100
Francesco Agustoni, Site 0543, 0382503938
- Recruiting
Istituto Nazionale Tumori Regina Elena
Rome, Roma, 00144
Federico Capuzzo, Site 0068, +390516225126
- Recruiting
Ospedale di Circolo e Fondazione Macchi Varese
Varese, 21100
Veronica Crespi, Site 0556, 390332278558
Australia9 sites, 9 recruiting
- Recruiting
Princess Alexandra Hospital
Brisbane, Queensland, 4102
Kenneth O'Byrne, Site 0127, 0731766505
- Recruiting
Canberra Hospital
Canberra, Australian Capital Territory, 2605
Geoffrey Peters, Site 0126, 610251242220
- Recruiting
Lyell McEwin Hospital
Elizabeth Vale, South Australia, 5112
Dainik Patel, Site 0129, 0433217127
- Recruiting
Frankston Hospital
Frankston, Victoria, 3199
Emma Beardsley, Site 0122, 61397847777
- Recruiting
Joondalup Health Campus
Joondalup, Western Australia, 6027
Arman Hasani, Site 0229, 61863889681
- Recruiting
Northern Hospital
Melbourne, Victoria, 3076
Vishal Boolell, Site 0121, 0434 479 184
- Recruiting
Tamworth Hospital
North Tamworth, New South Wales, 2340
Sunil Rai, Site 0212, 0267677760
- Recruiting
Orange Hospital
Orange, New South Wales, 2800
Robert Zielinski, Site 0128, 61263693380
- Recruiting
Latrobe Regional Health
Traralgon, Victoria, 3844
Evangeline Samuel, Site 0160, 03 5173 8000
Poland8 sites, 6 recruiting
- Recruiting
Centrum Onkologii im. Prof. Franciszka Lukaszczyka
Bydgoszcz, 85796
Bogdan Zurawski, Site 0076, 48501446778
- Completed
Local Institution - 0206
Gorlice, Lesser Poland Voivodeship, 38-300
- Recruiting
Pratia Onkologia Katowice
Katowice, 40-519
Agata Kachel-Flis, Site 0078, +48501714019
- Completed
Local Institution - 0079
Krakow, Lesser Poland Voivodeship, 30-727
- Recruiting
Uniwersytecki Szpital Kliniczny Nr 4 w Lublinie
Lublin, Lublin Voivodeship, 20-090
Izabela Chmielewska, Site 0080, +504051512
- Recruiting
Med-Polonia Sp. z o. o.
Poznan, Greater Poland Voivodeship, 60-693
Rodryg Ramlau, Site 0209, 48618549040
- Recruiting
Szpital Specjalistyczny w Prabutach Spolka z o.o.
Prabuty, 82-550
Anna Lowczak, Site 0077, +48503022396
- Recruiting
Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii
Wroclaw, Lower Silesian Voivodeship, 53-439
Krzysztof Rogoziewicz, Site 0205, 48693997463
South Korea8 sites, 7 recruiting
- Recruiting
Pusan National University Hospital
Busan, Pusan-Kwangyǒkshi, 49241
Jung Seop Eom, Site 0186, +82512407889
- Recruiting
Chungbuk National University Hospital
Cheongju-si, Chungcheongbuk-do [Chungbuk], 28644
Ki Hyeong Lee, Site 0163, 82432696015
- Recruiting
Gachon University Gil Medical Center
Namdong-gu, Incheon-gwangyeoksi [Incheon], 21565
Eun Kyung Cho, Site 0227, 82324603383
- Recruiting
Severance Hospital, Yonsei University Health System
Seoul, Seoul-teukbyeolsi [Seoul], 03722
Min Hee Hong, Site 0165, 821071541554
- Recruiting
Konkuk University Medical Center
Seoul, Seoul-teukbyeolsi [Seoul], 05030
Hee Joung Kim, Site 0228, 82220307525
- Completed
Local Institution - 0248
Seoul, Seoul-teukbyeolsi [Seoul], 06591
- Recruiting
Korea University Guro Hospital
Seoul, Seoul-teukbyeolsi [Seoul], 08308
Sung Yong Lee, Site 0146, 821022179216
- Recruiting
Pusan National University Yangsan Hospital
Yangsan, Kyǒngsangnam-do, 50612
Seong Hoon Yoon, Site 0211, 82-10-2870-9389
Mexico7 sites, 7 recruiting
- Recruiting
Hospital Civil Fray Antonio Alcalde
Guadalajara, Jalisco, 44280
Juan Vazquez Limon, Site 0178, 523316063096
- Recruiting
Gefarma (Atrys)
Mexico City, DIF, 11510
Patricia Sánchez Valencia, Site 0176, 5514743371
- Recruiting
Axis Heilsa S. de R.L. de C.V.
Monterrey, Nuevo León, 64040
Jorge Rodriguez Olivo, Site 0591, 8115545104
- Recruiting
Grupo Ollin Care
Pachuca, Hidalgo, 42000
Juan Salinas Garcia, Site 0579, 7711996481
- Recruiting
Unidad Médica Onco-hematológica
Puebla City, 72424
MIRIAM ESCAMILLA, Site 0181, +522222154940
- Recruiting
Centro de Infusion E Investigacion Oncologia de Saltillo S.C.
Saltillo, Coahuila, 25279
Eva Willars, Site 0583, 8446887477
- Recruiting
FAICIC S. de R.L. de C.V.
Veracruz, 91900
Erika Castillo, Site 0180, 522292071578
Turkey (Türkiye)7 sites, 7 recruiting
- Recruiting
Baskent University Dr. Turgut Noyan Research and Training Center
Adana, 01250
Ozgur Ozyilkan, Site 0197, +905353067506
- Recruiting
Hacettepe Universite Hastaneleri
Ankara, 06230
Mustafa Erman, Site 0201, +905334318506
- Recruiting
Ankara University Health Practice and Research Hospitals
Ankara, 06620
Yuksel Urun, Site 0194, 05337483275
- Recruiting
Ankara Bilkent Şehir Hastanesi
Ankara, 06800
Mehmet Ali Nahit Sendur, Site 0198, 905555306271
- Recruiting
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi
Istanbul, 34722
Mahmut Gumus, Site 0549, 00905063509061
- Recruiting
Ege Universitesi Hastanesi
Izmir, 35100
Pinar Gursoy, Site 0200, 905053693004
- Recruiting
I.E.U. Medical Point Hastanesi
Izmir, Karsiyaka, İzmir, 009035575
Cagatay Arslan, Site 0199, +905052642353
Argentina6 sites, 6 recruiting
- Recruiting
Hospital Italiano de Buenos Aires
ABB, Buenos Aires F.D., C1199ABB
Lorena Lupinacci, Site 0576, 5411495902008159
- Recruiting
Clinica Adventista Belgrano
CABA, Buenos Aires F.D., C1430EGF
Aldo Perfetti, Site 0573, 5491132682903
- Recruiting
Instituto Alexander Fleming
Ciudad Autónoma de Buenos Aires, Buenos Aires, C1426ANZ
Claudio Martin, Site 0575, 5491166936669
- Recruiting
IDIM - Instituto de Investigaciones Metabólicas
Ciudad de Buenos Aires, Buenos Aires, C1012AAR
Mara Rapaccioli, Site 0570, 1124870006
- Recruiting
Hospital Universitario Austral
Pilar, Buenos Aires, 1629
Nicolas Minatta, Site 0584, 5491138018573
- Recruiting
Sanatorio Plaza
Rosario, Santa Fe Province, 2000
Miriam Raimondo, Site 0595, +549341644-8821
Belgium6 sites, 6 recruiting
- Recruiting
UZ Brussel
Brussels, Bruxelles-Capitale, Région de, 1090
Lore Decoster, Site 0114, 3224775457
- Recruiting
Cliniques universitaires Saint-Luc
Brussels, Bruxelles-Capitale, Région de, 1200
Frank Nana Aboubakar, Site 0113, 3227648519
- Recruiting
AZ Maria Middelares
Ghent, Oost-Vlaanderen, 9000
Paul Germonpre, Site 0216, 3292468400
- Recruiting
Jessa Ziekenhuis
Hasselt, Limburg, 3500
Kristof Cuppens, Site 0215, +32472565987
- Recruiting
UZ Leuven
Leuven, Vlaams-Brabant, 3000
christophe Dooms, Site 0107, 003216340961
- Recruiting
Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman
Liège, 4000
Anne Sibille, Site 0109, 003243237400
Colombia6 sites, 6 recruiting
- Recruiting
Fundación Valle del Lili
Cali, Valle del Cauca Department, 760032
Alvaro Osorio Franco, Site 0173, 573012895296
- Recruiting
Fundación Cardiovascular de Colombia
Floridablanca, Santander Department, 681004
Martha Alarcon, Site 0170, 3187148911
- Recruiting
Clinica Medellin S.A
Medellín, 0
Andres Yepes, Site 0580, 573002608134
- Recruiting
Instituto Médico de Alta Tecnología S.A.S - IMAT S.A.S
Montería, COR, 230002
José Lobatón Ramirez, Site 0167, 47854344
- Recruiting
Clinica Somer
Rionegro, Antioquia, 054040
Camilo Vallejo, Site 0171, +573116349000
- Recruiting
Sociedad De Oncología y Hematología Del Cesar SAS
Valledupar, Cesar Department, 200001
Raimundo Manneh, Site 0253, 573157411877
Austria5 sites, 5 recruiting
- Recruiting
Medizinische Universität Graz
Graz, Styria, 8036
Gudrun Absenger, Site 0539, 4331638581318
- Recruiting
Kepler Universitätsklinikum
Linz, 4021
David Lang, Site 0530, 4373278066910
- Recruiting
Medizinische Universität Wien
Vienna, 1090
Thorsten Fuereder, Site 0533, 4314040044450
- Recruiting
Klinik Floridsdorf
Vienna, 1210
Maximilian Hochmair, Site 0673, +4319106041242
- Recruiting
Klinikum Wels-Grieskirchen GmbH
Wels, Upper Austria, 4600
Christian Trockenbacher, Site 0532, 4372424152382
Croatia5 sites, 5 recruiting
- Recruiting
Opća bolnica Dubrovnik
Dubrovnik, Dubrovnik-Neretva County, 20000
Tihana Boraska Jelavic, Site 0619, +385913458470
- Recruiting
Klinički bolnički centar Osijek
Osijek, 31000
Ivana Canjko, Site 0567, 385917223985
- Recruiting
Poliklinika MEDICO - Rijeka
Rijeka, Primorje-Gorski Kotar County, 51000
Dragan Trivanovic, Site 0664, 38598335797
- Recruiting
Klinički Bolnički Centar Split
Split, Split-Dalmatia County, 21000
Suzana Mladinov, Site 0639, +38521556434
- Recruiting
Clinic for lung diseases
Zagreb, 10000
Miroslav Samarzija, Site 0585, 012385251
Hungary5 sites, 5 recruiting
- Recruiting
Semmelweis Egyetem
Budapest, 1083
Veronika Muller, Site 0151, 36208259181
- Recruiting
Országos Korányi Pulmonológiai Intézet
Budapest, 1121
Gyula Ostoros, Site 0140, 3613913213
- Recruiting
Farkasgyepui Tudogyogyintezet
Farkasgyepű, Veszprém megye, 8582
Zsolt Kiraly, Site 0143, 36209264476
- Recruiting
Mátrai Gyógyintézet
Gyöngyös - Mátraháza, Heves County, 3233
Istvan Albert, Site 0144, 36202708215
- Recruiting
Petz Aladar Egyetemi Oktato Korhaz
Győr, 9024
Zsuzsanna Szalai, Site 0601, +36309758356
Ireland5 sites, 5 recruiting
- Recruiting
Cork University Hospital
Cork, T12 E8YV
Sinéad Noonan, Site 0102, +353879680182
- Recruiting
Mater Private Hospital - Dublin
Dublin, D07 WKW8
Jane Sui, Site 0476, +353(1)8034831
- Recruiting
St. James's Hospital
Dublin, D08 E9P6
Sinead Cuffe, Site 0101, 35314103756
- Recruiting
UCD School of Medicine Beacon Hospital
Dublin, D18 AK68
Lisa Prior, Site 0100, +35312935666
- Recruiting
Beaumont Hospital, Dublin
Dublin, D9
Jarushka Naidoo, Site 0106, 01-8092010
Israel5 sites, 5 recruiting
- Recruiting
Carmel Hospital
Haifa, Ḥeifā, 3436212
Ekaterina Shulman, Site 0613
- Recruiting
Hadassah Medical Center
Jerusalem, Jerusalem, 9112001
Hovav Nechushtan, Site 0544, 97226777836
- Recruiting
Rabin Medical Center
Petah Tikva, Central District, 4941492
Ofer Rotem, Site 0597, 9729378146
- Recruiting
Sheba Medical Center
Ramat Gan, Central District, 5265601
Jair Bar, Site 0596, 97235307096
- Recruiting
Yitzhak Shamir Medical Center
Tsrifin, Central District, 70300
Carmell Fink, Site 0600, +97289779713
Taiwan5 sites, 5 recruiting
- Recruiting
Taipei Medical University Shuang Ho Hospital
New Taipei City, 235
Kang-Yun Lee, Site 0337, 8862224900882714
- Recruiting
Chi Mei Hospital - Liouying Branch
Tainan, Tainan, 73657
Sheng-Yen Hsiao, Site 0341, 88666226999
- Recruiting
National Cheng Kung University Hospital
Tainan, 704
Chun-Hui Lee, Site 0335, 886-912777918
- Recruiting
National Taiwan University Hospital
Taipei, 10002
Jin-Yuan Shih, Site 0331, 88622312345662905
- Recruiting
Tri-Service General Hospital
Taipei City, Taipei, 114
Chen-Liang Tsai, Site 0631, 886287923311
Bulgaria4 sites, 3 recruiting
- Recruiting
MBAL Uni Hospital
Panagyurishte, Pazardzhik, 4500
Rossitza Krasteva, Site 0629, +359888938571
- Recruiting
Complex Oncology Center - Ruse EOOD
Rousse, 7002
Nikolay Nikolaev, Site 0627, 0887098616
- Completed
Local Institution - 0628
Sofia, Sofia (stolitsa), 1632
- Recruiting
Trakia Hospital
Stara Zagora, 6000
Rumyana Ilieva, Site 0635, 00359888431354
United Kingdom4 sites, 4 recruiting
- Recruiting
Heartlands Hospital
Birmingham, B9 5SS
Shobhit Baijal, Site 0092, +(44)01214247456
- Recruiting
The Royal Surrey County Hospital
Guildford, GU2 7XX
Ajay Mehta, Site 0090, 441483571122
- Recruiting
University College London Hospital
London, London, City of, NW1 2PG
Siow Lee, Site 0088, 442034479091
- Recruiting
Guy's & St Thomas' NHS Foundation Trust
London, London, City of, SE1 9RT
Alexandros Georgiou, Site 0091, 00442071882006
Greece3 sites, 3 recruiting
- Recruiting
Errikos Dunant Hospital Center
Athens, Attikí, 115 26
IOANNIS MOUNTZIOS, Site 0608, +306983519989
- Recruiting
Thoracic General Hospital of Athens "I Sotiria"
Athens, Attikí, 115 27
Konstantinos Syrigos, Site 0612, +302107700220
- Recruiting
University General Hospital of Larissa
Larissa, Thessalía, 41110
Athanasios Kotsakis, Site 0609, 302413502124
Portugal3 sites, 3 recruiting
- Recruiting
Instituto Portugês de Oncologia de Coimbra Francisco Gentil
Coimbra, 3000-075
Sara Povoa, Site 0510
- Recruiting
Instituto Português de Oncologia de Lisboa Francisco Gentil
Lisbon, Lisbon District, 1099-023
Telma Sequeira, Site 0509, +351 21 722 98 92
- Recruiting
Centro Hospitalar do Porto - Hospital de Santo António
Porto, 4099-001
Antonio Araujo, Site 0553, 351222077500x1729
Saudi Arabia3 sites, 3 recruiting
- Recruiting
King Faisal Specialist Hospital
Jeddah, Makkah Al Mukarramah, 23433
Ahmed Allehebi, Site 0614, +966555558414
- Recruiting
King Abdulaziz Medical City - National Guard Hospital
Riyadh, 11426
Turki Fayae, Site 0602, +966568559996
- Recruiting
King Faisal Specialist Hospital and Research Center
Riyadh, 12713
Hamed Alhusaini, Site 0562, +9664647272-49769
Thailand3 sites, 3 recruiting
- Recruiting
Chulalongkorn University
Bangkok, Bangkok, 10330
Virote Sriuranpong, Site 0563, 6622564533
- Recruiting
Songklanagarind hospital
Hat Yai, Changwat Songkhla, 90110
Patrapim Sunpaweravong, Site 0564, 6674451469
- Recruiting
Faculty of Medicine - Khon Kaen University
Muang, Changwat Khon Kaen, 40002
Aumkhae Sookprasert, Site 0565, 66840292822
Chile2 sites, 2 recruiting
- Recruiting
Bradfordhill
Recoleta, Santiago Metropolitan, 8420391
Carlos Rojas, Site 0574, +56998744662
- Recruiting
FALP
Santiago, Santiago Metropolitan, 7500921
Christian Caglevic, Site 0577, 56224457254
Hong Kong2 sites, 2 recruiting
- Recruiting
Queen Mary Hospital
Hksar, 0
Dennis Leung, Site 0466, 85222554095
- Recruiting
Queen Mary Hospital
Hksar, 0
Chung Man James Ho, Site 0379, 85222554999
Netherlands2 sites, 2 recruiting
- Recruiting
Nederlands Kanker Instituut Antoni van Leeuwenhoek (NKI AVL)
Amsterdam, North Holland, 1066 CX
Willemijn Theelen, Site 0594, 06-xxxxxxxx
- Recruiting
Maastricht UMC+
Maastricht, Limburg, 6229 HX
Lizza Hendriks, Site 0615, 31433875051
Canada1 site, 1 recruiting
- Recruiting
St. Marys Hospital Center
Montreal, Quebec, H3T 1M5
Adrian Langleben, Site 0559, 0000000000
Switzerland1 site, 1 recruiting
- Recruiting
Kantonsspital Münsterlingen - Spital Thurgau AG
Münsterlingen, 8596
Ioannis Metaxas, Site 0536, +41581447850
About this study
Official title: A Randomized, Double-Blind, Phase 3 Trial of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet chemotherapy versus placebo plus pembrolizumab plus platinum-doublet chemotherapy in participants with previously untreated, locally advanced or metastatic NSCLC with KRAS G12C mutation
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Being tested
- Adagrasib, Pembrolizumab, Carboplatin, Pemetrexed, Placebo
- Keywords
- Immunotherapy, KRAS, KRAS G12C, Targeted therapy
- Medical subject headings
- Carcinoma, Non-Small-Cell Lung
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AdagrasibDrug
Also called BMS-986503; KRAZATI®
Specified dose on specified days
PembrolizumabDrug
Also called KEYTRUDA®
Specified dose on specified days
CarboplatinDrug
Specified dose on specified days
PemetrexedDrug
Specified dose on specified days
PlaceboDrug
Specified dose on specified days
CisplatinDrug
Specified dose on specified days
| Study group | Role | What they receive |
|---|---|---|
| Adagrasib | Experimental | Not described Receives: Drug: Adagrasib; Drug: Pembrolizumab; Drug: Carboplatin; Drug: Pemetrexed; Drug: Cisplatin |
| Placebo | Placebo comparator | Not described Receives: Drug: Pembrolizumab; Drug: Carboplatin; Drug: Pemetrexed; Drug: Placebo; Drug: Cisplatin |
What is being measured
The primary outcome is the main question the study is designed to answer.
Progression Free Survival (PFS) as Assessed per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 by Blinded Independent Central Review (BICR)
Measured: Up to 7 years
Overall Survival (OS)
Measured: Up to 7 years
Secondary outcomes (11)
Overall Response (OR) as Assessed per RECIST v1.1 by BICR
Measured: Up to 7 years
Duration of Response (DOR) as Assessed per RECIST 1.1 by BICR
Measured: Up to 7 years
PFS as Assessed per RECIST v1.1 by Investigator
Measured: Up to 7 years
Number of Participants With Adverse Events (AEs)
Measured: Up to 90 days from last dose
Number of Participants With Serious Adverse Events (SAEs)
Measured: Up to 90 days from last dose
Number of Participants With AEs Leading to Dose Interruption
Measured: Up to 90 days from last dose
Number of Participants With AEs Leading to Dose Reduction
Measured: Up to 90 days from last dose
Number of Participants With AEs Leading to Treatment Discontinuation
Measured: Up to 90 days from last dose
Number of Deaths
Measured: Up to 90 days from last dose
Time to Definitive Deterioration by Non-Small Cell Lung Cancer-Symptom Assessment Questionnaire (NSCLC-SAQ) Total Score
Measured: Up to 7 years
Change From Baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-30) Scale/item Score
Measured: Up to 90 days from last dose
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Mar 2025
- Study start24 Apr 2025
- Primary completion7 Sep 2029 (estimated)
- Study completion30 Apr 2032 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Carcinoma, Non-Small-Cell LungStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 630 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Mirati Therapeutics Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Bristol-Myers Squibb, Study director, Bristol-Myers Squibb
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06875310
- Sponsor's protocol ID
- CA239-0004
- Other IDs
- 2024-515698-85, U1111-1309-5596, CA2390004
- Status last verified
- Oct 2026
- First submitted
- 7 Mar 2025
- Last updated
- 27 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- Yes
- FDA-regulated device
- No
- Individual data sharing
- Yes: BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myer Squibb's data sharing policy and process can be found at https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html
Study at a glance
From the registry record, last updated by the sponsor on 27 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized, Double-Blind, Phase 3 Trial of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
- ClinicalTrials.gov ID
- NCT06875310
- Acronym / sponsor ID
- CA239-0004
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Keywords
- Immunotherapy, KRAS, KRAS G12C, Targeted therapy
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 630 participants (estimated)
- Lead sponsor
- Mirati Therapeutics Inc.Industry (pharma, biotech, devices)
- Study start
- 24 Apr 2025 (actual)
- Primary completion
- 7 Sep 2029 (estimated)
- Study completion
- 30 Apr 2032 (estimated)
- First posted
- 13 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet chemotherapy versus placebo plus pembrolizumab plus platinum-doublet chemotherapy in participants with previously untreated, locally advanced or metastatic NSCLC with KRAS G12C mutation
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Adagrasib | Experimental | Drug: Adagrasib, Drug: Pembrolizumab, Drug: Carboplatin, Drug: Pemetrexed, Drug: Cisplatin |
| Placebo | Placebo comparator | Drug: Pembrolizumab, Drug: Carboplatin, Drug: Pemetrexed, Drug: Placebo, Drug: Cisplatin |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Histologically or cytologically confirmed diagnosis of non-squamous NSCLC with evidence of KRAS G12C mutation via tumor sample and/or circulating tumor deoxyribonucleic acid (ctDNA).
- Locally advanced or metastatic disease.
- Measurable disease via computed tomography (CT) or magnetic resonance imaging (MRI) per RECIST v1.1 criteria of at least 1 lesion.
- No prior systemic anti-cancer therapy given for advanced or metastatic disease.
- Not a candidate for definitive therapy (eg, chemoradiation or complete surgical resection).
Key exclusion criteria (7 listed)
- Participants with an active autoimmune or inflammatory disease requiring systemic treatment within 2 years.
- Uncontrolled or significant cardiovascular conditions within 6 months prior to enrollment that are ongoing or with risk of recurrence.
- Inadequate bone marrow or liver function or electrocardiogram (ECG) abnormalities.
- Ongoing treatment with concomitant medication known to cause prolonged QTc interval and that cannot be switched to alternative treatment prior to study entry.
- Treatment targeting KRAS G12C mutation (eg, sotorasib, adagrasib) in any setting.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AdagrasibAlso: BMS-986503; KRAZATI®Specified dose on specified days | Drug | Adagrasib |
| PembrolizumabAlso: KEYTRUDA®Specified dose on specified days | Drug | Adagrasib, Placebo |
| CarboplatinSpecified dose on specified days | Drug | Adagrasib, Placebo |
| PemetrexedSpecified dose on specified days | Drug | Adagrasib, Placebo |
| PlaceboSpecified dose on specified days | Drug | Placebo |
| CisplatinSpecified dose on specified days | Drug | Adagrasib, Placebo |
Primary outcome
Progression Free Survival (PFS) as Assessed per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 by Blinded Independent Central Review (BICR)
Time frame: Up to 7 years
Overall Survival (OS)
Time frame: Up to 7 years
11 secondary outcomes
Overall Response (OR) as Assessed per RECIST v1.1 by BICR
Time frame: Up to 7 years
Duration of Response (DOR) as Assessed per RECIST 1.1 by BICR
Time frame: Up to 7 years
PFS as Assessed per RECIST v1.1 by Investigator
Time frame: Up to 7 years
Number of Participants With Adverse Events (AEs)
Time frame: Up to 90 days from last dose
Number of Participants With Serious Adverse Events (SAEs)
Time frame: Up to 90 days from last dose
Number of Participants With AEs Leading to Dose Interruption
Time frame: Up to 90 days from last dose
Number of Participants With AEs Leading to Dose Reduction
Time frame: Up to 90 days from last dose
Number of Participants With AEs Leading to Treatment Discontinuation
Time frame: Up to 90 days from last dose
Number of Deaths
Time frame: Up to 90 days from last dose
Time to Definitive Deterioration by Non-Small Cell Lung Cancer-Symptom Assessment Questionnaire (NSCLC-SAQ) Total Score
Time frame: Up to 7 years
Change From Baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-30) Scale/item Score
Time frame: Up to 90 days from last dose
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Oct 2026.
- BMS Clinical Trial InformationLink provided by the sponsor.
- BMS Clinical Trial Patient RecruitingLink provided by the sponsor.
- Individual participant dataSharing planned: Yes. BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myer Squibb's data sharing policy and process can be found at https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html
Related trials for Carcinoma, Non-Small-Cell Lung
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
A Prospective ,Multicenter ,Non-interventional ,Real-world Study Observing Changes in Molecular Markers Osimertinib Targeted Therapy in EGFRm NSCLC
Non Small Cell Lung Cancer
RecruitingPhase 3
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Active, not recruitingPhase 2
Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer
Metastatic Lung Cancer, Advanced Non Small Cell Lung Cancer
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com contact
First line of the email MUST contain NCT # and Site #. contact
Bristol-Myers Squibb study director
Bristol-Myers Squibb
317 sites in 35 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing Adagrasib, Pembrolizumab and Carboplatin in people with Carcinoma, Non-Small-Cell Lung, run by Mirati Therapeutics Inc. at 317 sites in 35 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 27 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 317 sites in United States, China, Germany, France, Brazil and 30 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact BMS Clinical Trials Contact Center www.BMSClinicalTrials.com (855-907-3286, Clinical.Trials@bms.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Progression Free Survival (PFS) as Assessed per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 by Blinded Independent Central Review (BICR) (time frame: Up to 7 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2026.